Metabolic syndrome attenuates ulcerative colitis: Correlation with interleukin-10 and galectin-3 expression

Figure 5 Functional phenotype of immune cells in colonic mucosa. A: The graph and representative FACS plots displaying the percentage of CD8⁺ T cells derived from colonic mucosa of ulcerative colitis (UC) patients without and with metabolic syndrome (MetS). B: The graph and representative FACS plots displaying the percentage of T regulatory cells (CD4⁺Fox3⁺) derived from colonic mucosa of UC patients without and with MetS. C: The graph and representative FACS plots displaying the percentage of Galectin-3⁺ (Gal-3⁺) NKT (CD3⁺CD56⁺) cells derived from colonic mucosa of UC patients without and with MetS. D: The graph and representative FACS plots displaying the percentage of CD8⁺Foxp3⁺ cells derived from colonic mucosa of UC patients without and with MetS. E and F: The graph and representative FACS plots displaying the percentage of Interleukin-10 producing CD56⁺ and CD4⁺ cells derived from colonic mucosa of UC patients without and with MetS. Cellular make up of colon-infiltrating immune cells were examined by flow cytometry. The Student’s t or Mann-Whitney U test was applied to evaluate statistical significant differences among the two groups. IL-10: Interleukin-10; Gal-3: Galectin-3.